Direct-acting antiviral drugs improve the female sexual burden associated with chronic HCV infection

References

• Foster GR. Quality of life considerations for patients with chronic hepatitis C. J Viral Hepat. 2009;16:605–611.
   PubMed Web of Science ®Google Scholar
• Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology. 1998;27:209–212.
   PubMed Web of Science ®Google Scholar
• Karaivazoglou K, Iconomou G, Triantos C, et al. Fatigue and depressive symptoms associated with chronic viral hepatitis patients. Health-related quality of life (HRQOL). Ann Hepatol. 2010;9:419–427.
   PubMed Web of Science ®Google Scholar
• Ferri C. Erectile dysfunction and hepatitis C virus infection. JAMA. 2002;288:698–699.
   PubMed Web of Science ®Google Scholar
• Soykan A, Boztas H, Idilman R, et al. Sexual dysfunctions in HCV patients and its correlations with psychological and biological variables. Int J Impot Res. 2005;17:175–179.
   PubMed Web of Science ®Google Scholar
• Elshimi E, Morad W, Mohamad NE, et al. Female sexual dysfunction among Egyptian patients with chronic hepatitis C. J Sex Med. 2014;11:768–775. Available from: www.liver-eg.org
   PubMed Web of Science ®Google Scholar
• Simopoulos EF, Trinidad AC. Male erectile dysfunction: integrating psychopharmacology and psychotherapy. Gen Hosp Psychiatry. 2013;35:33–38.
   PubMed Web of Science ®Google Scholar
• Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191–208.
   PubMed Web of Science ®Google Scholar
• Wiegel M, Meston C, Rosen R. The Female Sexual Function Index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31:1–20.
   PubMed Web of Science ®Google Scholar
• Anis TH, Gheit SA, Saied HS, et al. Arabic translation of female sexual function index and validation in an Egyptian population. J Sex Med. 2011;8:3370–3378.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C. J Hepatol. 2018; 69:461–511.
   PubMed Web of Science ®Google Scholar
• Innes HA, McDonald SA, Dillon JF, et al. Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause -specific outcomes. Hepatology. 2015;62:355–364.
   PubMed Web of Science ®Google Scholar
• Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group. Hepatology. 1996;24:289–293.
   PubMed Web of Science ®Google Scholar
• Terkawi AS, Tsang S, AlKahtani GJ, et al. Development and validation of Arabic version of the hospital anxiety and depression scale. Saudi J Anaesth. 2017 May;11(Suppl 1):S11–S18.
   PubMedGoogle Scholar
• Seethala S, Hess R, Bossola M, et al. Sexual function in women receiving maintenance dialysis. Hemodial Int. 2010;14:55–60.
   PubMed Web of Science ®Google Scholar
• Harirchi I, Montazeri A, Zamani Bidokhti F, et al. Sexual function in breast cancer patients: a prospective study from Iran. J Exp Clin Cancer Res. 2012;31:20–25.
   PubMed Web of Science ®Google Scholar
• Grover S, Shah R, Dutt A, et al. Prevalence and pattern of sexual dysfunction in married females receiving antidepressants: an exploratory study. J Pharmacol Pharmacother. 2012;3:259–265.
   PubMedGoogle Scholar
• Witting K, Santtila P, Varjonen M, et al. Female sexual dysfunction, sexual distress and compatability with partner. J Sex Med. 2008;5:2587–2599.
   PubMed Web of Science ®Google Scholar
• Bonkovsky HL, Snow KK, Malet PF, et al. HALT-C trial group. Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis. J Hepatol. 2007;46:420–431.
   PubMed Web of Science ®Google Scholar
• Lauletta G, Russi S, Conteduca V, et al. Hepatitis C virus infection and mixed cryoglobulinemia. Clin Dev Immunol. 2012;2012:502156.
   PubMedGoogle Scholar
• Karaivazoglou K, Tsermpini EE, Assimakopoulos K, et al. Sexual functioning in patients with chronic hepatitis C: a systematic review. Eur J Gastroenterol Hepatol. 2017 Nov;29(11):1197–1205.
   PubMed Web of Science ®Google Scholar
• Evangelia-E T, Konstantinos A, Christos T. Sexual functioning in patients with chronic hepatitis C: a systematic review. Eur J Gastroenterol Hepato. 2016;10:0954–691.
   Google Scholar
• Snow KK, Bonkovsky HL, Fontana RJ, et al. Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2010;31:719–734.
   PubMed Web of Science ®Google Scholar
• El-Atrebi KA, El-Atrebi MA, El-Bassyouni HT. Sexual dysfunction in males with hepatitis C virus: relevance to histopathologic changes and peginterferon treatment. Saudi J Gastroenterol. 2011;17:406–410.
   PubMed Web of Science ®Google Scholar
• Dove LM, Rosen RC, Ramcharran D, et al. Decline in male sexual desire, function, and satisfaction during and after antiviral therapy for chronic hepatitis C. Gastroenterology. 2009;137:873–884.
   PubMed Web of Science ®Google Scholar
• Hsiao P-J, Hsieh P-F, Chou EC-L, et al. Anti-viral therapy and decreased sexual desire in patients with chronic hepatitis C. PLoS One. 2016;11:e0160450.
   PubMedGoogle Scholar
• Fawzy N, Atia H, Galal S, et al. Prevalence and risk factors of erectile dysfunction among chronic hepatitis C male patients treated with pegylated interferon-α and ribavirin. Egypt J Psychiatry. 2015;36:40.
   Google Scholar
• Kraus MR, Schäfer A, Bentink T, et al. Sexual dysfunction in males with chronic hepatitis C and antiviral therapy: interferon-induced functional androgen deficiency or depression?. J Endocrinol. 2005;185:345–352.
   PubMed Web of Science ®Google Scholar
• Malaguarnera M, Vicari E, Calogero A, et al. Sexual dysfunction in chronic hepatitis C virus patients treated with interferon alpha and ribavirin. J Interferon Cytokine Res. 2008;28:603–609.
   PubMed Web of Science ®Google Scholar
• Baranyi A, Meinitzer A, Stepan A, et al. A biopsychosocial model of interferon-alpha-induced depression in patients with chronic hepatitis C infection. Psychother Psychosom. 2013;82:332–340.
   PubMed Web of Science ®Google Scholar
• Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. Hepatology. 1999;29:264–270.
   PubMed Web of Science ®Google Scholar
• Elshimi E, Morad W, Mohamad NE. Male sexual dysfunction among egyptian patients with chronic hepatitis C virus infection before and after direct-acting antiviral drugs. J Sex Med. 2019;16:402–409. Available from: liver-eg.org
   PubMed Web of Science ®Google Scholar
• Mohamoud YA, Mumtaz GR, Riome S, et al. The epidemiology of hepatitis C virus in Egypt: A systematic review and data synthesis. BMC Infect Dis. 2013;13:288.
   PubMed Web of Science ®Google Scholar
• Terrault NA, Dodge JL, Murphy EL, et al. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology. 2013;57:881–889.
   PubMed Web of Science ®Google Scholar
• Vandelli C, Renzo F, Romanò L, et al. Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol. 2004;99:855–859.
   PubMed Web of Science ®Google Scholar